Old Web
English
Sign In
Acemap
>
authorDetail
>
Carl-Michael Staschen
Carl-Michael Staschen
Chemistry
Myeloid
Whole blood
Adverse effect
Spleen
3
Papers
46
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
INCB018424, an Oral, Selective JAK2 Inhibitor, Shows Significant Clinical Activity in a Phase I/II Study in Patients with Primary Myelofibrosis (PMF) and Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis (Post-PV/ET MF).
2007
Blood
Srdan Verstovsek
Hagop M. Kantarjian
Animesh D Pardanani
Deborah A. Thomas
Jorge E. Cortes
Ruben A. Mesa
John R. Redman
Carl-Michael Staschen
Jordan S. Fridman
Kris Vaddi
Ayalew Tefferi
Show All
Source
Cite
Save
Citations (42)
Equipotent Allosteric Effect of W84 on [3H]NMS‐Binding to Cardiac Muscarinic Receptors from Guinea‐Pig, Rat, and Pig*, **
1992
Pharmacology & Toxicology
Klaus Mohr
Carl-Michael Staschen
Manfred Ziegenhagen
Show All
Source
Cite
Save
Citations (4)
1